Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: Final results of a 5-year case-control study
A single dose of CYD-TDV conferred extended protection against more severe presentations of dengue. The study is limited by an absence of baseline dengue serostatus of the participants prior to vaccination but a large majority in this this cohort were likely dengue seropositive.
Authors
- Jesus Sarol (ORCID: https://orcid.org/0000-0003-1281-4485)
- Michelle Ylade (ORCID: https://orcid.org/0000-0002-2653-4460)
- Jedas Veronica Daag
- Maria Vinna Crisostomo (ORCID: https://orcid.org/0000-0002-4702-4929)
- Carolina Murgueitio Guzmán (ORCID: https://orcid.org/0009-0002-5612-1971)
- Kristal An Agrupis (ORCID: https://orcid.org/0000-0003-2917-2589)
- Ava Kristy Sy (ORCID: https://orcid.org/0000-0001-5143-1140)
- Jacqueline Deen (ORCID: https://orcid.org/0000-0001-8875-5026)
- March Helena Jane Lopez
- Olivia Dandan
- Jean Balabat
- Kiarah Louise Florendo
- Zoraida Yurango
Institutions
- University of Illinois Urbana-Champaign (US)
- Research Institute for Tropical Medicine (PH)
- München Klinik Bogenhausen (DE)
- Dr. Jose N. Rodriguez Memorial Hospital (PH)
- Cebu Technological University (PH)
- University of the Philippines Manila (PH)
Publication Details
- Journal
- Vaccine
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1016/j.vaccine.2025.127142
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi
- University of the Philippines
- Sanofi Pasteur